# Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/postmarketing-adverse-event-reporting-for-medical-products-and-dietary-supplements-during-a-pandemic/98000d9a-b1f7-4dbc-8bf5-8079e3a4b3a7 > FDA guidance document: Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic. Issue date: May 11, 2020. Get complete insights and analysis. --- ## Details - Title: Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic - Communication Type: Guidance Document - Product Type: dietary_supplements - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2020-05-11 - Last Changed: 2024-12-17 - Docket Number: FDA-2008-D-0610 ## Related Documents - [Expedited Programs for Serious Conditions | Drugs and Biologics](https://www.globalkeysolutions.net/guidances/guidance-document/expedited-programs-for-serious-conditions-drugs-and-biologics/d49c172d-43db-4e76-a0fd-1f51de9ecff3) - [Medical Product Communications That Are Consistent With the FDA-Required Labeling — Questions and Answers : Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/medical-product-communications-that-are-consistent-with-the-fda-required-labeling-questions-and-answers-guidance-for-industry/f5790b05-bd18-4236-a580-c2ae7ca2a444) - [Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers: Guidance for Industry and Review Staff](https://www.globalkeysolutions.net/guidances/guidance-document/drug-and-device-manufacturer-communications-with-payors-formulary-committees-and-similar-entities-questions-and-answers-guidance-for-industry-and-review-staff/fef61098-3bf5-4dc1-8f77-41453aebdc3c)